License Agreements - Additional Information (Details) - USD ($) $ in Thousands	1 Months Ended					3 Months Ended	6 Months Ended	12 Months Ended
	Mar. 31, 2026	Jun. 30, 2024	May 31, 2024	Apr. 30, 2024	Mar. 31, 2024	Mar. 31, 2026	Jun. 30, 2026	Dec. 31, 2024
License Agreements [Line Items]
Revenue							$ 20,000
Trace License Agreement
License Agreements [Line Items]
Upfront Payment Received				$ 15,000
Revenue								$ 15,000
Trace License Agreement \| Development And Regulatory Milestone
License Agreements [Line Items]
Milestone payment to be paid upon achivement of clinical and regulatory milestones					$ 80,000
Trace License Agreement \| Sales Milestone
License Agreements [Line Items]
Milestone payment to be paid upon achivement of sales milestones					250,000
Shionogi License Agreement
License Agreements [Line Items]
Upfront Payment Received			$ 150,000
Revenue	$ 20,000					$ 20,000		150,000
Achievement of clinical development milestone	$ 20,000
Shionogi License Agreement \| Development And Regulatory Milestone
License Agreements [Line Items]
Milestone payment to be paid upon achivement of clinical and regulatory milestones					275,000
Shionogi License Agreement \| Sales Milestone
License Agreements [Line Items]
Milestone payment to be paid upon achivement of sales milestones					$ 330,000
Neurocrine License Agreement
License Agreements [Line Items]
Upfront Payment Received		$ 2,500
Revenue								$ 2,500
Neurocrine License Agreement \| Development And Regulatory Milestone
License Agreements [Line Items]
Milestone payment to be paid upon achivement of clinical and regulatory milestones			24,800
Neurocrine License Agreement \| Sales Milestone
License Agreements [Line Items]
Milestone payment to be paid upon achivement of sales milestones			$ 175,000